In This Edition:
- What’s New at FMP Essentials: Stay updated on upcoming courses, practitioner meet-ups, exciting announcements, and new educational content.
- Inflammation and Cardiovascular Disease: The American College of Cardiology (ACC) has released a landmark 2025 statement emphasizing inflammation as a central driver of cardiovascular disease. Read more on this new statement below.
- Private Mastermind Podcast Spotlight: Don’t miss Dr. Elyaman’s conversation with Adam Lamb on clinician burnout and rediscovering purpose in medicine. They explore the personal and professional roots of burnout, how mindset and structure impact fulfillment, and practical ways to restore balance through systems, boundaries, and intentional living.
- Blog Feature: This month’s blog explores the link between omega-3 supplementation and atrial fibrillation. Learn how dose, form, and source influence heart rhythm, what research reveals about risk and benefit, and key considerations for optimizing omega-3 use in cardiovascular health.
- Stay informed, engaged, and ahead of the curve with this month’s updates!
What's New At FMP Essentials?
- Mastermind: We’re thrilled to share that the FMP Essentials Mastermind officially kicks off this month! 🎉 Our Silver and Gold cohorts are completely SOLD OUT, and we can’t wait to begin working with this incredible group of practitioners.
-
If you missed this round, don’t worry — you can still be part of what’s next. Join the waitlist to be the first to know when new seats open!
-
- Podcast Features: Dr. Elyaman joins The Trusted Pharmacist Podcast with Steve Hoffart for an insightful conversation on cholesterol, heart disease, and the hidden metabolic drivers behind both. For decades, cholesterol has been labeled the villain of heart disease, but nearly half of all fatal heart attacks occur in people with normal cholesterol levels. In this episode, Dr. Elyaman explores what we’re missing and how a deeper look at inflammation, insulin resistance, and oxidative stress reveals the real story behind cardiovascular risk. Listen here.
- Advanced Lipid Masterclass: Our advanced lipid course is on-demand! This 8-module course is packed with clinical insights to help you master lipidology through a functional medicine lens. Haven’t signed up yet? Click here to join now and get full access!
- Public Podcast: Our podcast episode with Dr. Deanna Minich on phytonutrients to support women through menopause previously released early to our Mastermind community is now publicly available on YouTube, Apple Podcasts, and Spotify. If you missed it the first time, now’s your chance to tune in. Don’t forget to subscribe to our YouTube channel for more expert insights. Click here to watch now!
Big News: ACC Puts Inflammation Center Stage
In a landmark 2025 scientific statement, the American College of Cardiology (ACC) formally acknowledges what functional medicine has emphasized for years: chronic, low-grade inflammation is a key driver of cardiovascular disease (CVD). The report elevates high-sensitivity C-reactive protein (hs-CRP) to a central role in both risk assessment and management, marking a major shift in conventional cardiology.
Highlights from the 2025 ACC Statement
-
Universal screening: The ACC recommends measuring hs-CRP alongside cholesterol in both primary and secondary prevention, calling it a “major clinical opportunity.”
-
Predictive strength: hs-CRP is as powerful—or more predictive—than LDL cholesterol for future cardiovascular events, even among patients with normal lipid levels.
-
Risk categories:
-
<1 mg/L: Low risk
-
1–3 mg/L: Average risk
-
>3 mg/L: High risk (recheck if >10 mg/L and the patient may be acutely ill)
-
-
Primary prevention: A persistently elevated hs-CRP (>3 mg/L) should prompt attention to lifestyle interventions such as diet, exercise, smoking cessation, and weight management. The ACC also notes that statin therapy may be beneficial even when LDL is normal in this setting.
-
Secondary prevention: Among individuals with established CVD, hs-CRP >2 mg/L indicates “residual inflammatory risk.” In these patients, low-dose colchicine (0.5 mg daily), now FDA-approved for reducing recurrent cardiovascular events, can be considered alongside standard lipid-lowering therapy.
Takeaway:
The ACC’s endorsement of hs-CRP testing signals a paradigm shift: inflammation is no longer a peripheral concept—it’s now recognized as a clinically actionable target in cardiovascular prevention and management.
References:
-
Mensah GA, Arnold N, Prabhu SD, Ridker PM, Welty FK. Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology. J Am Coll Cardiol. 2025 Sep 29:S0735-1097(25)07555-2. doi: 10.1016/j.jacc.2025.08.047. Epub ahead of print. PMID: 41020749.
Check Out This Month's Podcast Episode
🎧 New Podcast Episode: Overcoming Clinician Burnout
Dr. Elyaman sits down with entrepreneur and clinician coach Adam Lamb to discuss one of the most overlooked challenges in medicine, clinician burnout, and how to move from exhaustion to renewed purpose.
Here’s what they unpack:
- The Hidden Cost of Burnout: Why so many clinicians feel stuck, disconnected, or depleted despite career success
- Redefining Success: How to align your work with what truly matters, including purpose, health, and family
- Systems that Sustain You: Practical strategies to streamline workflow, delegate effectively, and protect your time
- Mindset Shifts: Learning to see possibility beyond traditional practice models and rediscover passion for medicine
- The Production, Profit, and Protection Framework: Adam’s method for creating balanced, thriving medical businesses
- Restoring Joy: How intentional routines, boundaries, and self-care rebuild energy and improve patient care
This episode offers refreshing and actionable insights for any practitioner ready to prevent or recover from burnout and design a career and life they love.
How to watch/listen: Log into your account, select the Bronze Mastermind, and scroll down to the "Expert Interviews, Insights & Podcasts" section to find the episode.
Check Out This Month's Blog Post
Omega-3s and Atrial Fibrillation: Understanding the Connection
Omega-3s are known for their heart-protective benefits—but can too much of a good thing pose risks? This month’s blog breaks down what the research says about the relationship between omega-3 supplementation and atrial fibrillation. Learn how dose, form, and source influence heart rhythm, why balance matters, and what to consider when recommending omega-3s in clinical practice.
Click here to view the article!
Help Us Grow Our Community!
Know a colleague who would benefit from being part of this Mastermind? Feel free to invite them to join us!
Thank you for being part of our community!
-The FMP Essentials Team
Responses